Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Advisory Committee Misperceptions Abound … At HHS
May 08 2025
•
By
Michael McCaughan
Eliminating industry representatives on advisory committees may be a small price to settle HHS Secretary Robert F. Kennedy Jr.'s concerns about conflicts of interest at the FDA.
(Shutterstock)
More from US Advisory Committees
More from Product Reviews